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Basel, SwitzerlandABSTRACT Interleukin-4 (IL-4) is an important class I cytokine involved in adaptive immunity. IL-4 binds with high affinity to the
single-pass transmembrane receptor IL-4Ra. Subsequently, IL-4Ra/IL-4 is believed to engage a second receptor chain, either
IL-2Rg or IL-13Ra1, to form type I or II receptor complexes, respectively. This ternary complex formation then triggers down-
stream signaling via intracellular Janus kinases bound to the cytoplasmic receptor tails. Here, we study the successive steps
of complex formation at the single cell level with confocal fluorescence imaging and correlation spectroscopy. We characterize
binding and signaling of fluorescently labeled IL-4 by flow cytometry of IL-4-dependent BaF3 cells. The affinity to ectopically
expressed IL-4Ra was then measured by single-color fluorescence correlation spectroscopy in adherent HEK293T cells that
express the components of the type II IL-4R but not type I. Finally, IL-4-induced complex formation was tested by dual-color
fluorescence cross-correlation spectroscopy. The data provide evidence for codiffusion of IL-4-A647 bound IL-4Ra and the
type II subunit IL-13Ra1 fused to enhanced green fluorescent protein, whereas type I complexes containing IL-2Rg and
JAK3 were not detected at the cell surface. This behavior may reflect hitherto undefined differences in the mode of receptor acti-
vation between type I (lymphoid) and type II (epithelial) receptor expressing cells.INTRODUCTIONThere is still medical need for improvement in under-
standing and manipulating cytokine and growth factor
signaling (1). Fostered by the continuous expansion and
development of new microscopic fluorescence-based
methods in the last decade, cell biologists now have access
to a broad spectrum of powerful tools to analyze molecular
mechanisms at the single cell level (2–4). Within the various
approaches to investigate protein-protein interactions in
live cells, fluorescence correlation spectroscopy (FCS) is
distinguished by providing dynamic information over a
broad range of timescales and single-molecule sensitivity
(5). With single-color FCS, the molar fractions of molecules
with different diffusion properties are temporally resolved.
Although changes in molecular mobility are not always
large enough for monitoring one-to-one interactions in
free solution, the dramatic drop in mobility when binding
to the cell membrane makes FCS the ideal tool to study
surface receptor binding (6–8).
For most receptor types, ligand binding induces subse-
quent intermolecular rearrangements within the plasma
membrane. Many cytokine receptors form dimers, although
higher order oligomers have also been described. Specific
interactions between similarly sized proteins can be
elegantly assessed with a dual-color extension (fluorescence
cross-correlation spectroscopy, FCCS) for which the signal
between two spectral channels is cross correlated (9–11).Submitted March 31, 2011, and accepted for publication October 11, 2011.
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0006-3495/11/11/2360/10 $2.00For example, confocal single-point FCCS in cell
membranes has been used to detect codiffusion of inter-
leukin-2 receptor a and MHC class I in T-lymphocytes, as
well as the existence of preformed dimers for ErbB2
(12,13).
In this study, we use confocal single-color FCS and dual-
color FCCS to observe receptor subunits of the interleukin-4
(IL-4) signaling pathway. IL-4R belongs to the class I cyto-
kine receptors, a family of 34 integral single-pass trans-
membrane proteins (14). In its activated, ligand-bound
form, the IL-4 receptor (IL-4R) constitutes a heterodimer,
composed of the IL-4Ra chain (CD 124) and either the
common g chain, IL-2Rg (CD 132; type I IL-4R) or the
IL-13Ra1 chain (type II IL-4R) as a coreceptor (15,16).
The expression pattern of the two coreceptors reflects their
different physiological roles. Type I IL-4R signaling is
crucial for the development and maturation of B-cells. In
addition, IL-4 is a key cytokine for the differentiation and
proliferation of a subset of T-helper cells (Th2), which
orchestrate B-cell activation and the production of humoral
antibodies. Whereas the type I IL-4R is lymphocyte specific,
the type II IL-4R is expressed in epithelia of most other
tissues including the brain. Although less is known about
the type II function, IL-4 signaling is nevertheless clearly
associated with widespread human diseases like asthma,
allergy, and atopic dermatitis (17,18).
IL-4 tightly binds the IL-4Ra chain with an affinity of
1–300 pM, whereas the affinity to each coreceptor chain is
negligible (19,20). Thus, a sequential binding model was
suggested, which could explain why the apparent affinitydoi: 10.1016/j.bpj.2011.10.014
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concentration of coreceptor IL-2Rg and, more indirectly,
why the signaling output increases over the whole range
of IL-4 binding (20). The IL-4/IL-4Ra binding interface
was thermodynamically mapped with single amino acid
resolution (21,22). Recently, crystal structures of the ternary
complex of the extracellular domains of IL-4R were
reported for both receptor types and ligands (23). However,
a direct observation of IL-4-induced ternary complex forma-
tion in the plasma membrane of living cells is still lacking.
Here, we present a systematic binding study to fill this
gap. First, we produced and characterized a recombinant,
fluorescently labeled IL-4 for which we quantified surface
binding and proliferation in IL-4-dependent BaF3 cells.
Because the small lymphoid cell types are not easily
amenable for ectopic expression and single-point confocal
FCS, we established adherent HEK293T cells as an experi-
mental platform for binding and oligomerization studies.
The affinity of a fluorescently labeled IL-4 to a truncated,
signaling deficient IL-4Ra mutant was in good agreement
to flow cytometry results obtained in BaF3. Using FCCS re-
vealed that the labeled IL-4-A647 significantly induced
cross correlation and thus complex formation with an
enhanced green fluorescent protein (eGFP)-tagged IL-
13a1 chain, whereas the recruitment of IL-2Rg was below
the detection limit. Our observations challenge the simple
cell surface dimerization activation model for type I IL-4R
and highlight the importance of observing protein-protein
interactions in a native cellular environment. In this regard,
we believe that our approach could prove useful to system-
atically assess other cytokine receptor types as well as
disease relevant mutants.MATERIALS AND METHODS
Protein labeling and analysis
Recombinant human IL-4 (Christian Heuser, Novartis Institutes for Bio-
Medical Research) was randomly labeled with the amino reactive dyes
AlexaFluor488 (A488) or AlexaFluor647 (A647) carboxylic acid succini-
midyl ester (Invitrogen, Darmstadt, Germany) and purified by gel filtration.
Additional details can be found in the Supporting Material.Gene expression and immunoblotting
Endogenously expressed levels of IL-4R components were analyzed by
generating cDNA from isolated HEK293T mRNA, followed by polymerase
chain reaction amplification of specific genes. Details for primer design and
experimental conditions can be found in the Supporting Material. Proteins
were analyzed by SDS-PAGE and immunoblotting. Transfected HEK293T
cells were washed with ice cold phosphate-buffered saline and lysed in
buffer (25 mM Tris pH 7.2, 150 mM NaCl, 5 mM MgCl2, 0.2% NP-40,
1 mM DTT) containing 5% glycerol and the Complete protease inhibitor
cocktail (Roche, Mannheim, Germany). Homogenized lysates were mixed
with NuPage sample buffer (Invitrogen) and 100 mM DTT, separated on
NuPage 4–12% Bis-Tris gradient gels (Invitrogen) and transferred to
a PVDF membrane. Phosphorylated STAT6 protein was detected with
a mouse monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz,Ca) followed by a horseradish-peroxidase conjugated secondary antiserum
(Sigma, Munich, Germany). Anti-GAPDH (Abcam, Cambridge, UK) was
used as an internal control. Horseradish-peroxidase was detected by ECL
Plus (Invitrogen) and chemiluminescence quantified with a LAS-3000
imager (Fuji, Du¨sseldorf, Germany).Cloning
Using standard methods, we generated cyan, green, and yellow fluorescent
protein (eCFP, eGFP, and eYFP) fusion constructs for full-length human
IL-4Ra transcription variant 1 (NCBI GI: 56788409) and human
IL-2Rg (NCBI GI:4557881) in the Clontech (Heidelberg, Germany)
vector system pEGFP-N1 and its color variants (e.g., pIL4Ra-eGFP-N1).
Short versions, e.g., pIL4Ram266-eGFP-N1 that is truncated after 35
amino acids of the cytoplasmic tail, are named after the remaining mature
amino acids. Nonfluorescent versions were generated by eGFP exci-
sion and religation (e.g., pIL4Ram266-N1). N-terminal hexahistidine
tags were added to generate e.g., pNHis-IL4Ra-eGFP-N1. In pNHis-
IL4Ram266-eGFP-N1 we removed the initial methionine of the eGFP
sequence to suppress cap-independent translation, then named pNHis-IL4-
Ram266-eGFP-N2.
Subcloning into pcDNA5/FRT (Invitrogen) yielded pcFRT-NHis-
IL4Ram266-eGFP-N2, with which the stable cell line H4G was made.
Introducing the early SV40 promoter in pcFRT upstream of the gene
yielded a vector system we designated pc2 (24). We introduced
IL-13Ra1 (NCBI GI: 26787975), and Fas (CD95, NCBI GI: 23510419)
into pc2 and adjusted the expression levels (24). A nonfluorescent version
of human JAK3 was expressed by excising eGFP from JAK3-eGFP-N1 (25)
and introducing additional stop codons at the C-terminus of the JAK3
(NCBI GI: 189095272). The JAK3 construct lacking the kinase domain
(pJAK3dJH1-eGFP-N1) has been described (25). To express human
STAT6 (NCBI GI: 23397677) we used pcDNA3.1-GS-STAT6 (Invitrogen).
For additional details see the Supporting Material.Cell culture
For flow cytometry we used a cell line derived from mouse IL-3-dependent
pre-B lymphocytes (BaF3, Novartis) (26) that stably expressed human
IL-4Ra and IL-13Ra1, conveying growth in response to human IL-4 and
IL-13 instead of IL-3. The BaF3 clone used for the proliferation assay
stably expressed human IL-4Ra (27). Cells were maintained in RPMI
1640 medium (Gibco) supplemented with 10% serum and 3–6 ng/ml
recombinant IL-4 (Novartis). Depletion of IL-4 induced apoptosis within
24 h. Proliferation curves were measured by seeding 1600 cells into
96-well round-bottom plates in RPMI without phenol red containing 10%
serum. Cells were stimulated with increasing amounts of recombinant
IL-4 (Invitrogen) or IL-4-A647 and evaluated after two days using a
luminescent cell viability assay (CellTiter-Glo, Promega, Mannheim,
Germany).
pcFRT-NHis-IL4Ram266-EGFP-N2 was introduced into the FRT
landing site of the host cell line Flp-In-293 (No. R750-07, Invitrogen) ac-
cording to the manufacturer’s recommendation. Maintenance of Flp-In cells
required fibronectin coating of the flasks at 10 mg/ml in phosphate-buffered
saline (Becton Dickinson, Heidelberg, Germany), followed by 30 min incu-
bation at 37C. A stable clone (H4G) was dilution cloned. The IL-4-A647
binding study was carried out in a No. 1.5 borosilicate glass chambered
384-well plate (Matrical, Spokane, WA). Before the experiment the cells
were washed and incubated 20 min with increasing concentrations of
IL-4-A647 in air buffer (150 mM NaCl, 20 mM Hepes pH7.4, 15 mM
Glucose, 46 mM Trehalose, 5.4 mM KCl, 0.85 mM MgSO4, 1.7 mM
CaCl2, 0.15 mg/ml bovine serum albumin).
For transient transfections, HEK293T cells were grown in Dulbecco’s
modified Eagle’s medium H21 containing 10% serum and seeded into
8-well chamber slides (LAB-TEK 8-well, Nunc, Langenselbold, Germany).Biophysical Journal 101(10) 2360–2369
2362 Weidemann et al.DNA was transiently transfected using Lipofectamine 2000 (Invitrogen)
and OptiMEM-I (Gibco). Cells were observed 24–48 h later in air buffer
at 22C.Flow cytometry
BaF3 cells were competitively labeled 3–4 days poststimulation using an
antibody directed against human IL-4Ra (M57-PE, Becton Dickinson)
and IL-4-A488. 7-Actinomycin D (7-AAD; Becton Dickinson) was used
for dead cell discrimination and the mouse IgG1 clone MOPC21 as anti-
body isotype control. Stained cells were measured using a FACSCalibur
(Becton Dickinson) flow cytometer. The signal was recorded with logarith-
mic amplification providing a four-decade log range and plotted as a histo-
gram. The geometric mean of the histogram (fluorescence per cell) was
used for calculating the binding curves. All data points were sampled in
triplicates. Additional details can be found in the Supporting Material.Confocal Imaging
Confocal images (see Fig. 2) were taken with a Zeiss Pascal LSM5 (Carl
Zeiss, Jena, Germany). The kinetics of IL-4-A647 binding (see Fig. 4)
was imaged with avalanche photodiodes on a customized Pickoscreen
confocal microscope (PS03, Evotec, Hamburg, Germany) based on the
commercial Insight Cell (Perkin Elmer, Waltham, MA). The time-lapsed
TIF-images were recorded by an Acapella-based software (MIPS, Evotec)
and mean intensities determined using a separate image analysis tool
(Optimas, Meyer Instruments, Houston, TX). The area a1 encompassing
the cell comprised three types of pixels: extracellular (ec), plasma
membrane (pm), and cytoplasmic (cp), whereas the area a2 was chosen
exclusively extracellular. The mean intensity in a1 is composed of the
concentration of bound or free protein, weighted with the corresponding
number of pixels plus background. The ratio
hF1ipx
hF2ipx
¼ a2
a1

pm½Lb þ ec

Lf
þ cp½BG
Lf
 (1)
transforms into the linear form B[Lb]þC, with B and C as constants for
a constant [Lf]. The latter condition was fulfilled during the competition
experiment (>60 min), for which the data could be represented by a first
order exponential decay (Origin Lab, Northampton, MA).FCS/FCCS
For FCS and FCCS (see Figs. 3 and 5) we used a Zeiss ConfoCor3 system
equipped with a C-Apochromat 40 1.2 W objective. FCS in free solution
was evaluated applying a standard 3D diffusion model including a triplet
term (9)
GðtÞ ¼ 1
cVeff
GTðtÞG3DðtÞ
GTðtÞ ¼
 
1 fnf þ fnf et=tnf
1 fnf
!
G3DðtÞ ¼
P
i
fi

1þ t
tdiff ;i
1
1þ t
S2tdiff ;i
1=2
; (2)
where fnf and tnf denote the fraction and time constant of the triplet-depen-
dent decay, and fi and tdiff,i the concentration (c) fraction and average dwell
time of the particle type i within the illuminated focal volume Veff, respec-
tively. The excitation intensity distribution is assumed to be 3D-Gaussian
and stretched along the optical axis by the structure parameter S ¼ z0/u0.
If F/BG < 20, the average intensity Fcor ¼ Ftot – BG and the fluctuationBiophysical Journal 101(10) 2360–2369amplitude Ncor¼ (1þ BG/Fcor)2 G1(t) were background (BG) corrected
and the average counts per particle (CPP), calculated according to CPP ¼
Fcor/Ncor. Diffusion coefficients and detection volume were derived with
a separate measurement of hydrolyzed A488 (Dt ¼ 400 mm2/s) (28,29)
and applying Veff ¼ S(4pDttdiff)3/2.
In cells, we recorded 5 runs for 15 s; runs showing significant intensity
changes (>10% changes during the course of the run) were discarded.
For pure receptor measurements in the stable cell line H4G, autocorrela-
tions were fitted with GðtÞ ¼ 1=cVeff GTðtÞG2DðtÞ. The A647-channel
was fitted with a combined 3D-2D-diffusion model function
GðtÞ ¼ 1
cVeff
½ fG3DðtÞ þ ð1 f ÞG2DðtÞ
G2DðtÞ ¼

1þ t
tdiff
1 ; (3)
where G3D(t), for i ¼ 1, accounted for the freely diffusing ligand in the
supernatant. For Kd determination, the fraction of membrane bound ligand
was determined. The slightly broadened molecular brightness distribution
of labeled IL-4-A647 (2 5 1.3 dye molecules) was neglected. Assuming
a simple 1:1 interaction relates the concentration of bound IL-4-A647
[Lb] ¼ c (1 – f) to the total concentration of applied ligand
½Lb ¼ 1
2

A
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
A2  4½LtRmax
p 

A ¼ ½Lt þ Rmax þ Kd
; (4)
where Rmax denotes the total concentration of binding sites. Equation (4)
was used to calculate the numerical binding isotherm. For Kd determination
of the dual-color experiments, we assumed [Lt] ~ [Lf] and computed Kd ¼
[Lf]([Rmax]  [Lb])/[Lb], where [Rmax] and [Lb] were expressed in surface
density units (mm2).
For coreceptor recruitment, we used the 3D-2D-diffusion model for both
the A647- and the eGFP-channel to account also for trace amounts of freely
diffusing eGFP-coupled protein species in the cytoplasm. The particle
numbers of the slow component from both channels was then used to calcu-
late the CC ratio (for details see text). Curve fitting was performed with the
scripting language Python.RESULTS AND DISCUSSION
IL-4 in free solution
To observe ligand-receptor interactions, we produced fluo-
rescently labeled, human IL-4. A mild labeling was aimed
to preserve the functional integrity of the protein. FCS al-
lowed resolving the relative amounts of free and conjugated
dye after purification (see Fig. S2 in the Supporting Mate-
rial). An average dye-protein stoichiometry of ~1:1 was
achieved for IL-4-A488 and 2:1 for IL-4-A647. FCS anal-
ysis revealed the absence of protein aggregates after
labeling and that the translational diffusion coefficients,
with ~100 mm2/s in aqueous buffer, match well with what
can be expected for a 15 kDa protein.IL-4R-mediated signaling
We first investigated the endogenous content of the IL-4R
machinery in the human cell line HEK293T, the cell type
we subsequently used for single cell FCS analysis. For
IL-4 Receptor Complex Formation 2363this, cellular mRNA was purified, transcribed into cDNA,
and analyzed with gene-specific primers (see Fig. S1). As
expected for an epithelial cell line, we identified
HEK293T as genuine type II IL-4R expressing cells, with
significant bands for the subunits IL-4Ra, JAK1,
IL13Ra1, and Tyk2. IL-2Rg and JAK3 were not detectable
while IL-4Ra mRNA expression was very weak. To verify
the functionality of the endogenous components, we as-
sayed STAT6 phosphorylation, a hallmark of IL-4R activa-
tion (Fig. 1). Because HEK293T cells do not express
endogenous STAT6, we therefore transiently overexpressed
human STAT6 before stimulation with different amounts
and types of ligands (Fig. 1 A, first 4 lanes). ComparingA
B
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FIGURE 1 IL-4R-mediated signaling. (A) Functionality of IL-4R
a-chain and (B) of coreceptor constructs assayed in HEK293T. Cells
were transiently transfected and ligand stimulated (0.6 nM). Pathway acti-
vation was detected by phospho-STAT6 immunoblotting; loading control
GAPDH. (C) Comparison of fluorescently labeled IL-4-A647 with wild-
type IL-4. Normalized proliferation curves measured for IL-4-dependent
BaF3 and phospho-STAT6 immunoblotting in STAT6 expressing
HEK293T.immunoblot band intensities shows that the activity of
randomly labeled IL-4-A647 is attenuated by about 10-
fold (Fig. 1 C). The concentration of the IL-4-A647 was
estimated based on FCS as for single cell binding experi-
ments (see below).
STAT6 phosphorylation was also used to functionally
characterize the different receptor constructs ectopically
expressed in HEK293T cells (Fig. 1, A and B). Transfection
of full-length IL-4Ra raises the nonstimulated baseline,
indicating signaling function (Fig. 1 A, lane 5). In contrast,
the cytoplasmic deletion construct IL4Ram266 dominantly
suppresses endogenous type II signaling, presumably by
outcompeting endogenous IL-4Ra for recruitment of
IL-13Ra1 into nonfunctional complexes (Fig. 1 A, lanes 8
and 10). Overexpression of the truncated IL-13 receptor
construct IL13Ra1m356-eGFP suppressed type II signaling
following stimulation with either IL-4 or IL-13 (Fig. 1 B,
lanes 16 and 26), although overexpression of the full-length,
tagged receptor chain IL13Ra1-eGFP did not influence
basal signal levels (Fig. 1 B, lanes 13 and 23).
Cells overexpressing IL2Rg-eGFP and JAK3 were also
inducible by IL-4 (Fig. 1 B, lane 18). However, signal trans-
duction now exclusively occurred via type I complexes, as
cotransfection of IL2Rg-eGFP with a JAK3dJH1-eGFP
construct lacking the catalytic domain (25) quantitatively
suppressed STAT6 phosphorylation (Fig. 1 B, lane 20). As
expected, the type II response following stimulation with
IL-13 involving the same endogenous IL-4Ra chains was
not affected, neither by the functional nor the dominant
negative type I coreceptor (Fig. 1 B, lanes 28 and 30). Over-
expression of the relevant subunits thus allows superimpos-
ing the desired type of IL-4R signaling in HEK293T cells.
The different tyrosine phosphorylation sites in the cyto-
plasmic IL-4Ra chain convey different downstream effects.
Whereas phosphorylation of Y575, Y603, Y631 (mature
numbering) regulates differentiation via STAT6, IL-4 also
acts as a growth factor for lymphoid cells via Y497 and
IRS-1 (16). To test the effect of random labeling on cell
proliferation, we used IL-4-dependent BaF3 cells that
express human IL-4Ra (27,30). These cells were passaged
with increasing amounts of nonlabeled IL-4 and fluorescent
IL-4-A647 and the cell densities measured two days post-
stimulation (Fig. 1 C). As for STAT6 phosphorylation,
IL-4-A647 exhibited a 10-fold reduced proliferative activity
as compared to nonlabeled IL-4. Thus, the changes in ligand
activity caused by labeling are equally affecting the
different tyrosines in the IL-4Ra tail.Cell surface binding of IL-4-A488 in BaF3
Native BaF3 cells depend on murine IL-3 for growth (26).
The cell line used for the binding studies stably expressed
both human type II IL-4R subunits, IL-4Ra, and
IL-13Ra1 (Novartis strain), and could thus instead be main-
tained by IL-4. We passaged the cells under a limiting IL-4Biophysical Journal 101(10) 2360–2369
2364 Weidemann et al.concentration and performed staining after 3 days of resting
time. Under these conditions, sufficient ligand-free receptor
was accessible at the cell surface to perform binding studies
by flow cytometry. The visual appearance of the cells was
unchanged, excluding apoptotic effects.
We used the fluorescence per cell readout to generate
binding curves and derive Kds. Staining the cells with
increasing concentrations of a phycoerythrin (PE) labeled
commercial antibody against the extracellular domain of
IL-4Ra (anti-CD124, M57-PE) led to hyperbolic, saturating
binding curves (Fig. 2 A). The antibody was titrated to
estimate the affinity and saturation values. Applying a 1:1
binding model, we obtained for M57-PE an apparent Kd
between 5 and 30 nM. Calibrating the signal yielded satura-
tion values between 600 and 2400 receptors per cell (not
shown). This magnitude of surface expression levels is in
good agreement to similar BaF3 cell lines described in the
literature (27).
Titrating IL-4-A488, we always obtained single phase
hyperbolic binding curves (Fig. 2 B). The dissociationA B
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FIGURE 2 Flow cytometry. (A) Binding curve of anti-IL-4Ra (M57) to
a type II IL-4R expressing BaF3 cell line. Numbers of bound PE per cell
were calibrated with fluorescent beads. Isotype control PE-labeled
MOPC21 (solid square). (B) Binding of IL-4-A488 to IL-4R expressing
BaF3 (inset). (C) Simultaneous binding of IL-4-A488 (solid circles) and
displacement of PE-labeled M57 (open circles) measured in the respective
color channels. (D) Comparative displacement of 10 nM PE-labeled M57
by nonlabeled IL-4 (open circles) or IL-4-488 (solid circles). (E) Confocal
images of HEK293T cells transiently expressing type I IL-4R constructs.
Imaging with A488 channel before and after administration of IL-4-A488
proves specific binding of the ligand (arrows).
Biophysical Journal 101(10) 2360–2369constant for IL-4-A488 was 175 4 nM, although saturation
could not always be fully achieved. This value is two orders
of magnitude lower compared to nonlabeled IL-4 (Kd ~150
pM) (27), reflecting the chemical modification and partial
inactivation of the protein. Interestingly, we found that
the M57 antibody competes with IL-4 for binding to the
receptor, facilitating competition experiments to assess the
binding specificity of IL-4-A488. M57-PE was efficiently
displaced by IL-4-A488, as well as by nonlabeled IL-4
(Fig. 2, C and D). In the presence of either 7.5 or 10 nM
M57-PE, 50% displacement was reached at ~10 nM IL-4-
A488. Assuming a 1:1 competition at the binding site, this
implies a roughly 10 nM dissociation constant for both
labeled ligand and antibody, confirming the affinity range
determined from the binding curves. As expected, antibody
displacement by nonlabeled IL-4 was more effective than by
labeled ligand (Fig. 2 D).Cell surface binding of IL-4-A647 in H4G
Combining microscopic methods with FCS allows for
observing cells, receptors, and ligands in real time under
quasi-equilibrium conditions. Some minutes after adminis-
tration of 10 nM IL-4-488, HEK293T cells transiently ex-
pressing a shortened, eCFP-tagged version of IL-4Ra and
a nonfluorescent IL-2Rg chain accumulated a seam of
A488-fluorescence, whereas the nontransfected neighboring
cells remained unstained (Fig. 2 E). Thus, binding speci-
ficity was sustained in HEK293T. We therefore asked
whether it was possible to recapitulate affinity measure-
ments of the labeled ligand in HEK293T by FCS. This
would provide a platform for single cell, single molecule
analysis of IL-4R complex formation that cannot easily be
performed in lymphocytes.
We chose eGFP for tagging of receptor chains, because it
is a well-established fluorophore for in vivo FCS applica-
tions and can be combined with IL-4-A647 for dual-color
applications. For convenient cell handling, we created
a stable cell line (H4G) expressing NHis-IL4Ram266-
eGFP, a tagged and truncated IL-4Ra retaining only 35
cytoplasmic amino acids before the eGFP (native tail length
is 569 amino acids). The truncated tail still contains the
box1 motif that promotes JAK1 binding (not shown). Unlike
the full-length receptor, at steady state these constructs
largely accumulate at the plasma membrane (Fig. 3B) in
a comparably narrow concentration range (Fig. S4).
For the ligand binding study, H4G cells were incubated
with increasing amounts of IL-4-A647. Cross sections
show ligand freely diffusing in the extracellular space, as
well as bound to the plasma membrane (Fig. 3 B). During
the experiment, some of the ligand was internalized and ap-
peared in small vesicles; however the uptake was very slow.
At 22C, cells could be measured for 2 h without significant
interference by internalized A647 fluorescence. FCS was
performed following a park-and-probe sequence: The cross
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(A) Dimensions of the detection volume as posi-
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Above the nucleus (N), fluorescence from filopodia
(FN), the extracellular compartment (EC), and the
cytoplasm (CP) may also be detected. (B) Confocal
cross sections of the stable cell line H4G in the
absence or presence of ligand IL4-A647. A typical
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(cross hair). (C) Normalized correlation curves
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(red, arrows). The molecular brightness of the
eGFP-tagged receptors for saturating IL-4 binding
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(inset).
IL-4 Receptor Complex Formation 2365section of the cells was scanned at z ¼ 3–6 mm distances
from the glass surface. At this height, the optical axis was
positioned in the middle of the nucleus. The laser focus
was then moved toward the apical membrane via the objec-
tive drive to z ¼ 8–10 mm (see also Fig. 3 A). From the
eGFP-channel, we obtained a diffusion coefficient of Dt ¼
0.4 5 0.11 mm2/s and a chromophore blinking time of
tnf ¼ 490 5 200 ms. Both the diffusion coefficient of the
receptors and the blinking time fall in the expected range
for a membrane anchored, eGFP-tagged single-pass trans-
membrane protein (31,32).
An example correlation curve for the ligand IL-4-A647 in
the apical membrane is shown in Fig. 3 C. Compared to the
fast decay, as measured in free solution, membrane binding
produces a pronounced second component with a correlation
time of the same order of magnitude as determined for the
receptor in the eGFP-channel (Fig. 3 D). Using a combined
3D-2D two-component model (Eq. 3), the molar fractions of
bound ligand (f2) can be derived from the fit and, in prin-
ciple, be used to calculate a binding curve. Based on the
eGFP channel, the average 2D receptor density in our cells
was 565 25 mm2, which is equivalent to an apparent 3D
concentration of ~100 nM within the focal volume. Because
FCS measurements are limited to nanomolar concentrations
of fluorescent particles, saturation could not be reached,
and an accurate Kd could not be derived by fitting model
functions. However, assuming the same molecular bright-
ness for IL-4-A647 in its different states and a simple
one-to-one binding model, a receptor concentration of
100 nM and Kd ¼ 10 nM adequately represents the data
(Fig. 3 C, inset). In addition, dual-color autocorrelationmeasurements allow evaluating the occupied receptor frac-
tion and the Kd for each individual cell. With an average
Kd ¼15 5 8 nM, the affinity between labeled IL-4 and
IL-4Ra was in good agreement with the values obtained
by flow cytometry.
Diffusion and binding of IL-4-A647 is sufficiently slow
such that surface binding could be followed by time-lapse
imaging (Fig. 4 A). For a kinetic experiment, a receptor-
expressing cell was selected in the eGFP-channel. Ligand
was carefully added in a small volume (1/10), such that
the image of the cell was kept in place and could be moni-
tored in the A647-channel. The slow diffusion-driven
expansion into the supernatant led to a successive increase
of intensity, first in the extracellular space and later, due
to receptor binding, at the plasma membrane. In Fig. 4 B,
we plotted the mean intensity of a region of interest encom-
passing the cell, normalized by a second region of interest
selected in the supernatant; under certain assumptions, this
ratio is proportional to the concentration of bound ligand
(Eq. 1). After some delay (15 min), this ratio increased line-
arly, and reached its maximum after 40 min, followed by
a slight decrease to a stable plateau. Adding a 10-fold excess
of unlabeled IL-4 initiated competition of the labeled by the
nonlabeled IL-4. From 80 min upward, the concentration of
bound ligand followed closely a first order exponential
decay. The time constant t ¼ 5.4 min directly relates to
the inverse off-rate koff ¼ 3  103 s1, which is in good
agreement with in vitro off-rates determined by surface plas-
mon resonance (koff ¼ 2.1  103 s1 (21)). Therefore, the
decrease in affinity for labeled relative to nonlabeled IL-4
must reflect a reduction of the on-rate.Biophysical Journal 101(10) 2360–2369
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2366 Weidemann et al.According to the crystal structure (Fig. S3), four out of 12
primary amino groups (11 lysines plus N-terminus) of IL-4
locate close to the IL-4Ra binding interface (K12, K61,
K77, and K84), where labeling would directly interfere
with binding. At an average of two dye labels per IL-4,
roughly 40% of IL-4 molecules should not be affected.
The strong reduction in affinity must be accounted for by
different mechanisms, e.g., by effects of the negatively
charged dyes on the electrostatic steering thought to
underlie the unusually high on-rate in IL-4 binding (21).
The transient maximum in the binding kinetics could indi-
cate receptor oligomerization. Assuming fast initial binding,
a shared ligand would lead to a subsequent slow decrease in
the concentration of bound ligand. Because IL-4Ra homo-
dimer-mediated signaling has been proposed (33), we tested
ligand-induced homotypic interactions of the IL-4Ra chains
with the photon counting histogram approach (34).We found
that themolecular brightness of eGFP-tagged receptors in the
plasma membrane of H4G cells was unchanged up to very
high IL-4 concentrations (Fig. 3 D, inset), excluding signifi-
cant ligand-induced receptor oligomerization in the plasma
membrane. We therefore suppose that the transient max-
imum is rather a result of phase shifts in the underlying
kinetic reactions. For the initial phase, in which the concen-Biophysical Journal 101(10) 2360–2369tration of membrane bound IL-4 rises linearly, it can be as-
sumed that all the ligands approaching the cell surface are
immediately bound, while equilibrium with dissociating
molecules is not yet fully established.IL-4-A647-induced coreceptor recruitment
in HEK293T
After ligand binding, the next crucial event in IL-4R activa-
tion is ternary complex formation of IL-4/IL-4Ra and either
of the two coreceptor chains. We therefore asked whether
labeled IL-4 could recruit the different eGFP-tagged
receptor chains into a complex (Fig. 5 A). Working with
a labeled ligand has the advantage that one can track and
quantify binding to the particular cell under study. We
applied dual-color FCCS to measure the fraction of
complexes carrying A647 coupled to the ligand and eGFP
coupled to the coreceptor. The approach required transient
coexpression of a nonfluorescent IL-4Ra chain (NHis-IL4-
Ram266) with an eGFP-tagged coreceptor chain. Labeled
IL-4 bound to the NHis-IL4Ram266-eGFP positive control
provided the maximum achievable cross-correlation ampli-
tude for the current alignment. To define the baseline we
used an eGFP-tagged version of the death receptor Fas
(CD95), not related to the IL-4 signaling pathway. Surface
partitioning of IL-2Rg at sufficient levels for FCS required
coexpression of nonfluorescent JAK3 that, like other JAKs,
act as a chaperone for endoplasmic reticulum export of the
associated receptor (35) but, like IL-2Rg is not normally
expressed in HEK293T cells (Fig. S1 (25)).
Applying IL-4-A647 at concentrations slightly above Kd
(~20–50 nM) led to quantitative binding. Confocal images
of cells selected for FCCS expressing combinations of
a nonfluorescent, ligand binding a-chain with different
eGFP-tagged coreceptors were visually similar (Fig. S5).
We selected cells where a large fraction of the receptors
showed quantitative colocalization at the plasma membrane,
and the plasma membrane distributions appeared spatially
homogenous. The transiently transfected cells exhibited
a broad distribution of expression levels. As judged from
the autocorrelation amplitudes in the eGFP-channel, we
measured cells with on average ~200 eGFP receptors per
mm2 in the plasma membrane, covering the broad range of
30–680 receptors per mm2. The correlation curves measured
in transiently transfected cells contained slightly different
correlation times as compared to NHis-IL4Ram266-eGFP
in the stable cell line H4G: The fast correlation time was
shifted up to the lower millisecond regime with a persistent
molar fraction of ~30%.We think this cannot be due to chro-
mophore blinking but rather represents a combination of
blinking and trace amounts of eGFP-tagged protein species
freely diffusing in the cytoplasm. Indeed, some of the cells
showed a faint background of diffuse intensity in confocal
cross sections. Either proteolysis or escape from initial
AUG translation initiation may be an underlying biological
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IL-4 Receptor Complex Formation 2367reason (36). To cope with a freely diffusing species, we eval-
uated channels, eGFP and A647, with the 3D1C-2D1C
diffusion model. For the positive control NHis-IL4-
Ram266-eGFP we obtained with Dt2 ¼ 0.135 0.08 mm2/s
a somewhat smaller value than in the stable H4G cell line;
the difference is most likely attributed to the alternate fitting
model. The other eGFP-tagged receptors ranged between
0.1 and 0.3 mm2/s.
FCCS in dual-color mode produces three correlation
curves, one for each color channel and the cross-correlation
curve (Fig. 5, B–D). We evaluated the membrane-bound
particle numbers for the eGFP, the A647, and the cross-
correlation channel (Ng, Nr, and Ngr) by fitting. The fraction
of formed complexes was determined as the ratio designated
CCg ¼ Ngr/Ng or CCr ¼ Ngr/Nr. Due to asymmetric expres-
sion levels either more red or more green particles are in the
observation volume, therefore one of the CC values is
always larger for the same number of formed complexes.
To minimize this bias, we always took the maximum CC
(either CCg or CCr) as a representative value for the partic-
ular cell (designated CCmax). For NHis-IL4Ram266-eGFP
(positive control) we measured CCmax ¼ 51 5 17% and
for the FasR-eGFP (negative control) CCmax ¼ 9 5 6%.
Having the experimental range defined, we obtained for
IL2Rg-eGFP CCmax ¼ 9 5 6% and for IL13Ra1-eGFP
CCmax ¼ 41 5 17%. Thus, whereas ligand-mediated
IL-2Rg recruitment into the ternary complex was indistin-
guishable from the negative control; IL-4-A647-dependent
recruitment of IL-13Ra1 was significant (Fig. 5 E).
How can the drastic difference of the measured cross-
correlation levels for the two IL-4R types be explained?
One possibility is that the newly formed type I complexes
are cleared from the membrane so rapidly that they become
undetectable before the background of freely diffusingsubunits. Because we observe the receptors under steady
state with continued presence of ligand, clearance due to
endocytosis would have to be a much faster process than
complex formation. However, a significant internalization
during the course of the experiment is not supported by our
observations, as we did not observe a large accumulation of
fluorescent ligand or truncated, eGFP-tagged receptors in
the cytoplasm of the cells. Another possibility is selective
bleaching of type I complexes in the focal volume. Immobi-
lization of IL-2Rg/JAK3may bemediated by ligand-induced
interactions with the cytoskeleton, for example the actin
cortex (32). However, we did not observe a pronounced
bleaching of eGFP-tagged receptors in the presence of
ligand. Finally, chemical labeling might reduce the affinity
such that the type I complex lifetime becomes too short
with respect to the diffusion times (<90ms). It is conceivable
that binding at the cell surface selects IL-4-A647 species for
which the dyes have been attached distant to the IL-4Ra
binding interface. From these eight accessible amino groups,
only K126 seems to be sterically involved in the IL-2Rg
binding (Fig. S3). Recalling that two dye molecules were
on average conjugated to IL-4-A647, ~75% of the ligands
should not be labeled at K126. However, for IL13-Ra1, the
CC-values reached in average as much as 80% of the positive
control; a small reduction as compared to the 100-fold loss in
apparent surface affinity toward IL-4Ra. The data therefore
instead suggest a much lower affinity toward IL-2Rg—
such that the fraction of formed complexes remains below
the detection threshold for our FCCS approach.CONCLUSIONS
Here we analyze, to our knowledge for the first time, fluo-
rescently tagged IL-4 receptor subunits with singleBiophysical Journal 101(10) 2360–2369
2368 Weidemann et al.molecule resolution in living cells. The surface affinity of
labeled IL-4 was determined with flow cytometry and
single-color FCS. The results were remarkably consistent
despite the fact that the surface receptor densities in the
murine, lymphoid BaF3 cells were rather physiological,
whereas ectopic overexpression in epithelial HEK293T
cells produced three to four orders of magnitude higher
values. Chemical labeling of IL-4 reduced the binding
affinity about 100-fold. In contrast, downstream signaling
activity was reduced by a factor of 10-fold, as indepen-
dently assayed by STAT6 phosphorylation and IRS1/2-
dependent proliferation. Thus, the IL-4R signaling
machinery translates the loss in ligand affinity with a smaller
conversion factor, indicating that a subnanomolar affinity is
not a stringent prerequisite for generating a full signaling
response (20).
A key step for signal transduction is the cross activation
of JAKs bound to the receptor’s cytoplasmic tails. It is
generally believed that ligand-induced dimerization is
necessary to bring the JAKs into a signaling productive
spatial orientation (37). We recently showed in membrane
blebs that neither IL-4Ra nor IL-2Rg have a propensity
to exist as preformed dimers (24). Therefore, ligand
binding must, at some stage in the cascade, drive complex
formation. We assayed IL-4-A647 for its activity to induce
dimerization by dual-color FCCS. To our surprise, we
failed to detect recruitment of IL-2Rg, whereas dimeriza-
tion with IL-13Ra1 was almost in saturation. These
observations imply that the affinity for the two coreceptor
subtypes differ dramatically, contrasting biochemical
studies using recombinantly expressed extracellular
domains (23). We conclude that the cytoplasmic portions
of the receptors in conjunction with the membrane
environment in living cells have significant impact on the
binding thermodynamics. Whereas for type II signaling
the data are in agreement with the canonical ligand-
induced dimerization model, the behavior of type I recep-
tor subunits is rather intriguing and calls for further
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